Understanding Tricuspid Valve Stenosis
At a Glance
Tricuspid valve stenosis is a rare narrowing of the valve between the right atrium and right ventricle. Rheumatic heart disease is the most common cause worldwide, but pacemaker leads, carcinoid syndrome, congenital changes, or a mass can also obstruct flow.
Tricuspid valve stenosis is a rare heart condition where the tricuspid valve—the door between the right upper chamber (atrium) and right lower chamber (ventricle) of your heart—becomes narrowed and stiff [1]. This narrowing makes it difficult for blood to flow forward into the right ventricle, which is the chamber responsible for pumping blood to your lungs. (Note: You may also hear the term tricuspid regurgitation, which is when the valve leaks backward; they are different, though they can happen together).
If you have been diagnosed with this condition, you may find that your local doctor or general cardiologist has limited direct experience with it. In developed nations like the United States, tricuspid stenosis is found in fewer than 1% of patients with heart valve disease [1]. Because it is so uncommon, it is often managed at specialized heart centers where teams see a higher volume of complex valve cases.
How the Valve Fails
The tricuspid valve consists of three thin flaps of tissue called leaflets. In a healthy heart, these leaflets open wide to let blood fill the right ventricle and snap shut to prevent blood from leaking backward. In tricuspid stenosis, these leaflets become thick, rigid, or fused together [2].
This creates a biological “bottleneck” that leads to two main issues:
- Obstruction of Emptying: The right atrium cannot empty properly into the right ventricle [3]. This causes blood to back up in the atrium, increasing the pressure inside that chamber.
- Systemic Venous Congestion: Because the heart cannot pull blood forward efficiently, pressure builds up “upstream” in the veins throughout your body. This often leads to fluid buildup in the liver and legs, known as systemic venous congestion [4][5].
The Role of Rheumatic Heart Disease
The most common cause of tricuspid stenosis worldwide is rheumatic heart disease [1], which is permanent valve damage that can develop years after a person has an untreated or “hidden” case of rheumatic fever (often following a strep throat infection).
Rheumatic disease rarely attacks the tricuspid valve alone. It is usually found alongside damage to the valves on the left side of the heart, most commonly the mitral valve [6][7]. When rheumatic fever causes stenosis, the valve leaflets often develop commissural fusion—a process where the edges of the leaflets “zip” together, leaving only a tiny opening for blood to pass through [2][8].
Other Potential Causes
While rheumatic disease is the leading cause, several other factors can lead to a narrowed tricuspid valve:
- Pacemaker and ICD Leads: Electronic leads (wires) placed through the tricuspid valve for a pacemaker or ICD (implantable cardioverter-defibrillator) can sometimes interfere with the valve [9]. Over time, these leads may cause the valve tissue to become scarred or inflamed, or the lead itself may get “stuck” to a leaflet, preventing it from opening [10][11].
- Carcinoid Syndrome: This is a rare condition where certain neuroendocrine tumors release chemicals (like serotonin) into the bloodstream [12]. These chemicals can cause tough, fibrous plaques to form on the surface of the heart valves [13]. While this more often causes the valve to leak (regurgitation), it can also make the valve so stiff that it cannot open, leading to stenosis [14][15].
- Congenital Factors: In very rare cases, people are born with a tricuspid valve that is too small or improperly formed [1]. A related but distinct condition called tricuspid atresia occurs when there is an absent or imperforate connection between the right atrium and ventricle, which is a severe birth defect typically caught in infancy [16].
- External Obstruction: Sometimes the valve itself is healthy, but something else blocks the opening. This can happen if a non-cancerous tumor, such as a myxoma, grows in the right atrium and sits over the valve like a “cork in a bottle” [17].
Understanding the Gradient
Doctors measure the severity of the narrowing using a diastolic gradient [3]. This is a measurement of the difference in pressure between the right atrium and the right ventricle as the heart tries to push blood through the narrow opening. A higher gradient generally indicates a more severe obstruction. Because the pressure on the right side of the heart is naturally low, even a small-looking gradient can represent significant disease that requires careful monitoring [3].
Common questions in this guide
What is tricuspid valve stenosis?
What usually causes tricuspid valve stenosis?
Can a pacemaker or ICD lead cause tricuspid stenosis?
How do doctors measure the severity of tricuspid stenosis?
Is tricuspid stenosis the same as tricuspid regurgitation?
What symptoms can tricuspid valve stenosis cause?
Can tricuspid stenosis occur with disease in other heart valves?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Causes of narrowing
What could be causing the narrowing of my tricuspid valve?
Measuring the narrowing
How do doctors measure how severe my valve narrowing is?
Where care happens
Should I seek care at a specialized heart center for my valve?
Get notified when new evidence is published on tricuspid valve stenosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
Surgical management of tricuspid stenosis.
Cevasco M, Shekar PS
Annals of cardiothoracic surgery 2017; (6(3)):275-282 doi:10.21037/acs.2017.05.14.
PMID: 28706872 - 2
Three-Dimensional Echocardiographic Evaluation of Rheumatic Tricuspid Valve Disease: A Prospective Single-Center Cohort Study.
Abdelnabi M, Almaghraby A, Gamal M, et al.
Reviews in cardiovascular medicine 2026; (27(3)):48678 doi:10.31083/RCM48678.
PMID: 41923722 - 3
Invasive Hemodynamic Characteristics in Patients Undergoing Transcatheter Tricuspid Valve-In-Valve Implantation for Treatment of Tricuspid Stenosis.
Patel K, Sadeghi S, Aboulhosn J
World journal for pediatric & congenital heart surgery 2020; (11(4)):411-416 doi:10.1177/2150135120910366.
PMID: 32645780 - 4
Bioprosthetic tricuspid valve stenosis: a case series.
Hirata K, Tengan T, Wake M, et al.
European heart journal. Case reports 2019; (3(3)) doi:10.1093/ehjcr/ytz110.
PMID: 31367735 - 5
Resolution of chylopericardium after balloon dilatation of tricuspid valve stenosis in a Labrador Retriever.
Groesser N, Beijerink N
Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology 2022; (42()):47-51 doi:10.1016/j.jvc.2022.05.005.
PMID: 35738154 - 6
Balloon dilatation of isolated severe tricuspid valve stenosis.
Bhardwaj R, Sharma R
Indian heart journal 2015; (67 Suppl 3()):S78-80.
PMID: 26995441 - 7
Predominant Rheumatic Tricuspid Stenosis.
Alizadeh L, Vainrib AF, Ro R, et al.
JACC. Case reports 2025; (30(33)):104808 doi:10.1016/j.jaccas.2025.104808.
PMID: 41136055 - 8
Pattern and Extent of Tricuspid Valve Involvement in Chronic Rheumatic Heart Disease.
Rashid MB, Parvin T, Ahmed CM, et al.
Mymensingh medical journal : MMJ 2018; (27(1)):120-125.
PMID: 29459602 - 9
Tricuspid stenosis: An emerging disease in cardiac implantable electronic devices era. Case report and literature review.
Husain A, Raja FT, Fatallah A, et al.
Journal of cardiology cases 2017; (15(6)):190-193 doi:10.1016/j.jccase.2017.02.003.
PMID: 30279777 - 10
[Heart failure provoked by a pacemaker lead-induced tricuspid stenosis].
Chaudesaygues E, Ferrini M, Ritz B
Annales de cardiologie et d'angeiologie 2017; (66(2)):109-111 doi:10.1016/j.ancard.2016.09.037.
PMID: 28277270 - 11
[Lead-related infective endocarditis with massive vegetation causing severe functionnal tricuspid stenosis].
Aboukhoudir F, Boulet V, Rekik S, Pansieri M
Annales de cardiologie et d'angeiologie 2017; (66(5)):326-329 doi:10.1016/j.ancard.2017.09.012.
PMID: 29050737 - 12
Carcinoid Heart Disease: Pathophysiology, Pathology, Clinical Manifestations, and Management.
Jin C, Sharma AN, Thevakumar B, et al.
Cardiology 2021; (146(1)):65-73 doi:10.1159/000507847.
PMID: 33070143 - 13
Carcinoid heart disease.
Hassan SA, Banchs J, Iliescu C, et al.
Heart (British Cardiac Society) 2017; (103(19)):1488-1495 doi:10.1136/heartjnl-2017-311261.
PMID: 28596302 - 14
Carcinoid heart disease in patients with midgut neuroendocrine tumours.
Delhomme C, Walter T, Arangalage D, et al.
Journal of neuroendocrinology 2023; (35(4)):e13262 doi:10.1111/jne.13262.
PMID: 37005217 - 15
A clinical and echocardiographic case report of carcinoid-related valvular heart disease.
Ebrahimi AJ, Marogil P, Von Mering G, Ahmed M
European heart journal. Case reports 2020; (4(6)):1-4 doi:10.1093/ehjcr/ytaa363.
PMID: 33442593 - 16
Cyanotic Heart Disease.
Dolan L, Swamynathan R, Frishman WH, Aronow WS
Cardiology in review 2026; doi:10.1097/CRD.0000000000001482.
PMID: 42804659 - 17
Surgical treatment of a giant right atrial myxoma.
Numaguchi R, Hashimoto M, Koshima R, Mitsube K
Surgical case reports 2020; (6(1)):165 doi:10.1186/s40792-020-00923-9.
PMID: 32642805
This page explains tricuspid valve stenosis and its possible causes for informational purposes only and does not constitute medical advice. A cardiologist or specialized heart team should interpret your symptoms and valve pressure measurements.